Electrocompetent Cells Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4167671
- 153 Pages
- January 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Electrocompetent Cells market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Electrocompetent Cells market segmented into
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Based on the end-use, the global Electrocompetent Cells market classified into
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Based on geography, the global Electrocompetent Cells market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ELECTROCOMPETENT CELLS INDUSTRY
2.1 Summary about Electrocompetent Cells Industry
2.2 Electrocompetent Cells Market Trends
2.2.1 Electrocompetent Cells Production & Consumption Trends
2.2.2 Electrocompetent Cells Demand Structure Trends
2.3 Electrocompetent Cells Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Cloned Competent Cells
4.2.2 Agrobacterium tumefaciens Competent Cells
4.2.3 Expression Competent Cells
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Subcloning & Routine Cloning
4.3.2 Phage Display Library Construction
4.3.3 Toxic/Unstable Dna Cloning
4.3.4 High-Throughput Cloning
4.3.5 Protein Expression
4.3.6 Mutagenesis
4.3.7 Single-Stranded Dna Production
4.3.8 Bacmid creation
4.3.9 Cre-lox recombination (PIR1/PIR2)
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Cloned Competent Cells
5.2.2 Agrobacterium tumefaciens Competent Cells
5.2.3 Expression Competent Cells
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Subcloning & Routine Cloning
5.3.2 Phage Display Library Construction
5.3.3 Toxic/Unstable Dna Cloning
5.3.4 High-Throughput Cloning
5.3.5 Protein Expression
5.3.6 Mutagenesis
5.3.7 Single-Stranded Dna Production
5.3.8 Bacmid creation
5.3.9 Cre-lox recombination (PIR1/PIR2)
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Cloned Competent Cells
6.2.2 Agrobacterium tumefaciens Competent Cells
6.2.3 Expression Competent Cells
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Subcloning & Routine Cloning
6.3.2 Phage Display Library Construction
6.3.3 Toxic/Unstable Dna Cloning
6.3.4 High-Throughput Cloning
6.3.5 Protein Expression
6.3.6 Mutagenesis
6.3.7 Single-Stranded Dna Production
6.3.8 Bacmid creation
6.3.9 Cre-lox recombination (PIR1/PIR2)
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Cloned Competent Cells
7.2.2 Agrobacterium tumefaciens Competent Cells
7.2.3 Expression Competent Cells
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Subcloning & Routine Cloning
7.3.2 Phage Display Library Construction
7.3.3 Toxic/Unstable Dna Cloning
7.3.4 High-Throughput Cloning
7.3.5 Protein Expression
7.3.6 Mutagenesis
7.3.7 Single-Stranded Dna Production
7.3.8 Bacmid creation
7.3.9 Cre-lox recombination (PIR1/PIR2)
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Cloned Competent Cells
8.2.2 Agrobacterium tumefaciens Competent Cells
8.2.3 Expression Competent Cells
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Subcloning & Routine Cloning
8.3.2 Phage Display Library Construction
8.3.3 Toxic/Unstable Dna Cloning
8.3.4 High-Throughput Cloning
8.3.5 Protein Expression
8.3.6 Mutagenesis
8.3.7 Single-Stranded Dna Production
8.3.8 Bacmid creation
8.3.9 Cre-lox recombination (PIR1/PIR2)
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Cloned Competent Cells
9.2.2 Agrobacterium tumefaciens Competent Cells
9.2.3 Expression Competent Cells
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Subcloning & Routine Cloning
9.3.2 Phage Display Library Construction
9.3.3 Toxic/Unstable Dna Cloning
9.3.4 High-Throughput Cloning
9.3.5 Protein Expression
9.3.6 Mutagenesis
9.3.7 Single-Stranded Dna Production
9.3.8 Bacmid creation
9.3.9 Cre-lox recombination (PIR1/PIR2)
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck KGaA
10.1.2 Thermo Fisher Scientific
10.1.3 Agilent Technologies
10.1.4 Takara Bio
10.1.5 Promega Corporation
10.1.6 Beijing TransGen Biotech
10.1.7 GeneScript Corporation
10.1.8 Yeastern Biotech
10.1.9 New England Biolabs
10.1.10 QIAGEN N.V.
10.1.11 OriGene Technologies
10.1.12 Lucigen
10.1.13 Zymo Research
10.1.14 Bio-Rad Laboratories
10.1.15 Bioline
10.1.16 Delphi Genetics
10.1.17 IBA GmBH
10.1.18 Cell Applications
10.1.19 BioDynamics Laboratory
10.1.20 Scarab Genomics
10.2 Electrocompetent Cells Sales Date of Major Players (2017-2020e)
10.2.1 Merck KGaA
10.2.2 Thermo Fisher Scientific
10.2.3 Agilent Technologies
10.2.4 Takara Bio
10.2.5 Promega Corporation
10.2.6 Beijing TransGen Biotech
10.2.7 GeneScript Corporation
10.2.8 Yeastern Biotech
10.2.9 New England Biolabs
10.2.10 QIAGEN N.V.
10.2.11 OriGene Technologies
10.2.12 Lucigen
10.2.13 Zymo Research
10.2.14 Bio-Rad Laboratories
10.2.15 Bioline
10.2.16 Delphi Genetics
10.2.17 IBA GmBH
10.2.18 Cell Applications
10.2.19 BioDynamics Laboratory
10.2.20 Scarab Genomics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Electrocompetent Cells Product Type Overview
2.Table Electrocompetent Cells Product Type Market Share List
3.Table Electrocompetent Cells Product Type of Major Players
4.Table Brief Introduction of Merck KGaA
5.Table Brief Introduction of Thermo Fisher Scientific
6.Table Brief Introduction of Agilent Technologies
7.Table Brief Introduction of Takara Bio
8.Table Brief Introduction of Promega Corporation
9.Table Brief Introduction of Beijing TransGen Biotech
10.Table Brief Introduction of GeneScript Corporation
11.Table Brief Introduction of Yeastern Biotech
12.Table Brief Introduction of New England Biolabs
13.Table Brief Introduction of QIAGEN N.V.
14.Table Brief Introduction of OriGene Technologies
15.Table Brief Introduction of Lucigen
16.Table Brief Introduction of Zymo Research
17.Table Brief Introduction of Bio-Rad Laboratories
18.Table Brief Introduction of Bioline
19.Table Brief Introduction of Delphi Genetics
20.Table Brief Introduction of IBA GmBH
21.Table Brief Introduction of Cell Applications
22.Table Brief Introduction of BioDynamics Laboratory
23.Table Brief Introduction of Scarab Genomics
24.Table Products & Services of Merck KGaA
25.Table Products & Services of Thermo Fisher Scientific
26.Table Products & Services of Agilent Technologies
27.Table Products & Services of Takara Bio
28.Table Products & Services of Promega Corporation
29.Table Products & Services of Beijing TransGen Biotech
30.Table Products & Services of GeneScript Corporation
31.Table Products & Services of Yeastern Biotech
32.Table Products & Services of New England Biolabs
33.Table Products & Services of QIAGEN N.V.
34.Table Products & Services of OriGene Technologies
35.Table Products & Services of Lucigen
36.Table Products & Services of Zymo Research
37.Table Products & Services of Bio-Rad Laboratories
38.Table Products & Services of Bioline
39.Table Products & Services of Delphi Genetics
40.Table Products & Services of IBA GmBH
41.Table Products & Services of Cell Applications
42.Table Products & Services of BioDynamics Laboratory
43.Table Products & Services of Scarab Genomics
44.Table Market Distribution of Major Players
45.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
46.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
47.Table Global Electrocompetent Cells Market Forecast (Million USD) by Region 2021f-2026f
48.Table Global Electrocompetent Cells Market Forecast (Million USD) Share by Region 2021f-2026f
49.Table Global Electrocompetent Cells Market Forecast (Million USD) by Demand 2021f-2026f
50.Table Global Electrocompetent Cells Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
